GO:0036149 phosphatidylinositol acyl-chain remodeling: Lipid Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0036149 phosphatidylinositol acyl-chain remodeling is the biological process that exchanges fatty acid chains on phosphatidylinositol (PI) through sequential deacylation and re-acylation reactions.
• This remodeling generates PI molecular species with distinct acyl chain compositions, which are critical for membrane organization and signaling.
• Key enzymes include phospholipase A1 (PLA1) and acyltransferases such as MBOAT7 and LPLAT, which determine the sn-1 and sn-2 acyl chains of PI.
• Acyl chain saturation of PI and its phosphorylated derivatives (phosphoinositides) regulates membrane order and nanodomain formation, influencing protein recruitment and signaling.
• Dysregulation of PI acyl-chain remodeling has been linked to cancer, neurodegeneration, and metabolic disorders.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential to dissect the causal roles of remodeling enzymes in health and disease.
Description
Phosphatidylinositol (PI) is a minor but essential phospholipid that serves as a precursor for phosphoinositides, which regulate diverse cellular processes including signal transduction, membrane trafficking, and cell survival. The biological function of PI is profoundly influenced by its acyl chain composition, which determines its biophysical properties and interaction with proteins. GO:0036149, phosphatidylinositol acyl-chain remodeling, describes the enzymatic process that remodels the fatty acid chains of PI through deacylation and re-acylation cycles, thereby generating a diverse array of PI molecular species. This process is conserved from yeast to humans and is critical for maintaining membrane homeostasis and enabling specific signaling events. Research over the past two decades has elucidated the enzymes and mechanisms underlying PI acyl-chain remodeling. In yeast, the ER is a major site of phospholipid remodeling, where phospholipases and acyltransferases act sequentially to incorporate specific acyl chains into PI. In mammals, the remodeling pathway is more complex, with multiple enzymes exhibiting tissue-specific expression and substrate preferences. The acyl chain composition of PI affects the formation of nanodomains and the recruitment of effector proteins, thereby influencing downstream signaling. Consequently, dysregulation of PI remodeling enzymes has been implicated in various diseases, including cancer and neurological disorders. Understanding GO:0036149 is therefore crucial for researchers studying lipid signaling, membrane biology, and related pathologies. This article provides a comprehensive overview of the definition, mechanisms, key genes, and research methods associated with phosphatidylinositol acyl-chain remodeling, with a focus on how CRISPR-based models can advance this field.
phosphatidylinositol acyl-chain remodeling At A Glance
| GO ID | GO:0036149 |
|---|---|
| GO term | phosphatidylinositol acyl-chain remodeling |
| Ontology | biological_process |
| Synonym | phosphatidylinositol acyl-chain remodelling |
| Major function | Remodeling the acyl chains of phosphatidylinositol via deacylation and re-acylation to generate PI species with different fatty acid compositions |
| Cellular location | Endoplasmic reticulum and other membranes |
| Key enzymes | Phospholipase A1, acyltransferases (e.g., MBOAT7, LPLAT) |
| Conservation | Conserved from yeast to mammals |
| Related processes | Phospholipid turnover, phosphoinositide signaling, membrane lipid homeostasis |
What Is GO:0036149?
GO:0036149 phosphatidylinositol acyl-chain remodeling is defined as the biological process that remodels the acyl chains of phosphatidylinositol through sequential deacylation and re-acylation reactions, resulting in phosphatidylinositol molecules containing different types of fatty acid acyl chains. This process alters the hydrophobic portion of PI without changing the inositol headgroup, thereby creating molecular diversity that impacts membrane properties and protein interactions.
Why Is phosphatidylinositol acyl-chain remodeling Important in Cell Biology?
Phosphatidylinositol acyl-chain remodeling is fundamentally important because it dictates the biophysical properties of PI and its phosphorylated derivatives, which in turn regulate a myriad of cellular processes including signal transduction, membrane trafficking, and cell growth. The acyl chain composition of PI influences the formation of membrane nanodomains and the recruitment of signaling proteins, thereby affecting downstream pathways. Moreover, remodeling enzymes are often dysregulated in diseases such as cancer and neurodegeneration, making them potential therapeutic targets. Thus, understanding GO:0036149 provides insights into both basic membrane biology and disease mechanisms.
• Regulates membrane fluidity and organization by altering the saturation and length of PI acyl chains.
• Controls the availability of PI as a substrate for phosphoinositide kinases and phosphatases, thereby impacting signaling.
• Influences the formation of signaling nanodomains at the plasma membrane.
• Modulates protein-lipid interactions and recruitment of effector proteins to membranes.
• Plays a role in cell division and stem cell maintenance in model organisms.
• Dysregulation is associated with cancer, neurodegeneration, and metabolic disorders.
• Provides potential biomarkers for disease diagnosis and progression.
• Offers targets for therapeutic intervention in lipid-related pathologies.
• Essential for understanding lipid diversity and its functional consequences.
• Enables comparative studies across species to reveal evolutionary conservation.
What Happens During phosphatidylinositol acyl-chain remodeling?
Deacylation: Removal of Fatty Acid Chains
In simple terms: First, enzymes cut off the existing fatty acid chains from phosphatidylinositol.
The remodeling process begins with the deacylation of phosphatidylinositol, typically at the sn-1 position, by phospholipase A1 (PLA1) or related enzymes. This step generates lysophosphatidylinositol (LPI), which serves as an intermediate for subsequent re-acylation. In yeast, the ER is a major site for this reaction, where phospholipases act on PI to initiate remodeling. The activity of PLA1 is crucial for determining the sn-1 acyl chain composition of PI, as demonstrated in Caenorhabditis elegans where PLA1 and acyltransferases are involved in stem cell divisions.
Re-acylation: Incorporation of New Fatty Acid Chains
In simple terms: Next, other enzymes attach new fatty acid chains to the lysophosphatidylinositol.
Following deacylation, lysophosphatidylinositol is re-acylated by acyltransferases, which transfer acyl-CoA or other acyl donors to the sn-2 position, and possibly the sn-1 position, thereby generating mature PI with a new acyl chain composition. In mammals, enzymes such as MBOAT7 (LPIAT1) and LPLAT (lysophospholipid acyltransferases) catalyze these reactions, with specificity for different acyl-CoA species. This step is critical for incorporating polyunsaturated fatty acids, such as arachidonic acid, into PI, which affects signaling and membrane properties.
Acyl Chain Selection and Molecular Diversity
In simple terms: The enzymes choose which fatty acids to add, creating many different types of phosphatidylinositol.
The acyl chain composition of PI is highly diverse, with variations in chain length and saturation. This diversity arises from the substrate specificity of remodeling enzymes and the availability of acyl-CoA pools. For example, in yeast, distinct PI molecular species are sorted and remodeled en route to the plasma membrane, indicating a role for acyl chain-based sorting. In mammals, comparative analysis across species and tissues has revealed conserved and tissue-specific patterns of phosphoinositide acyl chain diversity. The saturation of acyl chains regulates the order of phosphatidylinositol 4,5-bisphosphate nanodomains, impacting their function.
Coupling with Phosphoinositide Synthesis and Turnover
In simple terms: Remodeling is linked to the production and breakdown of signaling lipids.
Acyl chain remodeling is intimately coupled with the synthesis and consumption of phosphoinositides. For instance, acyl chain selection can influence the substrate pool for phosphoinositide kinases and phosphatases, thereby affecting signaling. In yeast, phospholipid turnover and acyl chain remodeling in the ER are coordinated to maintain membrane homeostasis. This coupling ensures that the acyl chain composition of phosphoinositides is tailored to their specific signaling functions.
Subcellular Organization and Transport
In simple terms: Remodeling happens in specific cell locations and the products are transported to where they are needed.
Acyl chain remodeling occurs primarily in the endoplasmic reticulum, but the remodeled PI species are transported to other membranes, such as the plasma membrane and Golgi. In yeast, ESI-MS/MS analysis revealed acyl chain-based sorting of distinct PI molecular species en route to the plasma membrane. This subcellular organization ensures that specific PI species are delivered to appropriate compartments, where they participate in signaling and membrane trafficking.
Key Genes Involved in GO:0036149 phosphatidylinositol acyl-chain remodeling
The following genes and proteins are key players in phosphatidylinositol acyl-chain remodeling, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PLA1 (e.g., PLAAT, DDHD) | Phospholipase A1 that removes sn-1 acyl chain from PI | Initiates remodeling; studied in C. elegans stem cell divisions |
| MBOAT7 (LPIAT1) | Lysophosphatidylinositol acyltransferase that incorporates arachidonic acid into PI | Critical for PI acyl chain composition; linked to liver disease and neurodevelopment |
| LPLAT (e.g., LPGAT1, LPEAT1) | Lysophospholipid acyltransferases that re-acylate LPI | Determine sn-2 acyl chain; involved in diverse lipid metabolic pathways |
| LPCAT (e.g., LPCAT1-4) | Lysophosphatidylcholine acyltransferases, may also act on LPI | Contribute to acyl chain remodeling; potential crosstalk with PC metabolism |
| PLA2 (e.g., PLA2G4, PLA2G6) | Phospholipase A2 that can remove sn-2 acyl chain | May participate in PI remodeling; linked to neurodegeneration |
| ABHD (e.g., ABHD2, ABHD3) | Alpha/beta hydrolase domain-containing proteins with PLA1 activity | Emerging roles in lipid remodeling; potential new players |
| PITP (e.g., PITPNA, PITPNB) | Phosphatidylinositol transfer proteins that bind PI and facilitate exchange | Influence acyl chain selectivity and transfer between membranes |
| CERT (e.g., CERT1) | Ceramide transfer protein, not directly PI remodeling but related lipid transfer | Context for lipid homeostasis |
| Sac1 (yeast) | Phosphoinositide phosphatase, affects PI levels and remodeling | Model for coupling remodeling with signaling |
| Pik1 (yeast) | Phosphatidylinositol 4-kinase, generates PI4P from PI | Links remodeling to phosphoinositide synthesis |
| Sec14 (yeast) | Phosphatidylinositol transfer protein | Studied for PI transfer and remodeling |
| Opi1 (yeast) | Transcriptional repressor regulated by PI and PA | Connects remodeling to gene expression |
| Mdm1 (yeast) | ER-vacuole tethering protein, affects lipid homeostasis | Potential role in PI remodeling |
| Lro1 (yeast) | Diacylglycerol acyltransferase, contributes to lipid storage | Indirectly affects acyl chain pools |
| Are1/Are2 (yeast) | Acyl-CoA:sterol acyltransferases | Modulate acyl-CoA availability for remodeling |
| Human MBOAT7 | Same as MBOAT7 above | Disease associations |
| Human PLAAT3 | Phospholipase A/acyltransferase, may remodel PI | Potential role in cancer |
| Human DDHD1 | Phospholipase A1, implicated in hereditary spastic paraplegia | Disease link |
How Is phosphatidylinositol acyl-chain remodeling Regulated?
The process of phosphatidylinositol acyl-chain remodeling is regulated at multiple levels. Enzyme activity can be modulated by substrate availability, post-translational modifications, and interaction with other proteins. In yeast, the ER environment and lipid composition influence the activity of remodeling enzymes. In mammals, the expression of remodeling enzymes is tissue-specific and can be regulated by metabolic and hormonal signals. Additionally, the acyl-CoA pool, which provides substrates for re-acylation, is controlled by fatty acid synthesis and uptake, thereby indirectly regulating remodeling. Cross-talk with phosphoinositide signaling pathways also feeds back to modulate remodeling enzyme activity.
phosphatidylinositol acyl-chain remodeling and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MBOAT7 | Hepatocellular carcinoma, NAFLD | Liver-specific knockout mouse, CRISPR KO in HepG2 cells |
| DDHD1 | Hereditary spastic paraplegia | Knock-in mouse with patient mutation, iPSC-derived neurons |
| PLA2G6 | Neurodegeneration with brain iron accumulation | Knockout mouse, patient-derived fibroblasts |
| PITPNA | Cancer, neurological disorders | Overexpression and knockout in cell lines |
| LPLAT | Metabolic syndrome | CRISPR knockout in adipocytes, liver organoids |
Cancer
Alterations in phosphatidylinositol acyl-chain remodeling have been observed in various cancers. For example, MBOAT7 expression is dysregulated in hepatocellular carcinoma, and its loss promotes liver tumorigenesis in mice. The acyl chain composition of PI affects signaling pathways such as PI3K/AKT, which are frequently mutated in cancer. Thus, targeting remodeling enzymes may offer therapeutic opportunities.
Neurodegeneration
Mutations in genes involved in PI remodeling, such as DDHD1, are associated with hereditary spastic paraplegia, a neurodegenerative disorder. Proper acyl chain composition of PI is essential for neuronal membrane function and signaling, and its disruption can lead to neurodegeneration.
Metabolic Disorders
Dysregulation of PI remodeling has been linked to metabolic disorders including non-alcoholic fatty liver disease (NAFLD) and insulin resistance. MBOAT7 variants are associated with NAFLD progression, highlighting the importance of PI acyl chain composition in liver metabolism.
From phosphatidylinositol acyl-chain remodeling-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of MBOAT7 loss on PI acyl chain composition? | MBOAT7 knockout cell line (e.g., Huh7) followed by lipidomics |
| How does a disease-associated point mutation in DDHD1 affect enzyme activity? | Knock-in of mutant DDHD1 in HEK293 cells, activity assay |
| Does overexpression of LPLAT alter phosphoinositide signaling? | Doxycycline-inducible overexpression in HeLa cells, live-cell imaging |
| What is the role of PLA1 in stem cell division? | C. elegans knockout of PLA1 homolog, phenotypic analysis |
| How does acyl chain saturation affect PI(4,5)P2 nanodomains? | Knock-in of desaturase to alter saturation, super-resolution microscopy |
| Can CRISPR screening identify novel remodeling enzymes? | Genome-wide CRISPR knockout library in lipid reporter cells |
How to Study the phosphatidylinositol acyl-chain remodeling Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ESI-MS/MS lipidomics | PI molecular species composition | Profiling acyl chain changes in cells/tissues |
| CRISPR-Cas9 knockout | Gene function loss | Studying remodeling enzyme roles |
| CRISPR knock-in | Introduction of specific mutations | Modeling disease variants |
| Fluorescence microscopy | Localization and dynamics of lipids/proteins | Visualizing nanodomains |
| Enzyme activity assay | Catalytic activity of phospholipases/acyltransferases | Characterizing enzyme kinetics |
| RNA-seq | Transcriptional changes | Assessing compensatory gene expression |
| Co-immunoprecipitation | Protein-protein interactions | Identifying remodeling complexes |
| Super-resolution imaging | Nanoscale membrane organization | Studying PI(4,5)P2 nanodomains |
Lipidomics and Mass Spectrometry
Mass spectrometry-based lipidomics is the gold standard for analyzing PI acyl chain composition. ESI-MS/MS has been used to profile PI molecular species in yeast subcellular membranes, revealing acyl chain-based sorting. In mammalian cells, targeted lipidomics can quantify changes in PI species upon genetic manipulation.
CRISPR-Cas9 Genome Editing
CRISPR-Cas9 allows precise knockout, knock-in, or point mutation of genes involved in PI remodeling. For example, knockout of MBOAT7 in cell lines has been used to study its role in liver cancer. Knock-in of disease-associated mutations can model human disorders.
Fluorescence Microscopy and Imaging
Live-cell imaging with fluorescently tagged lipid-binding domains (e.g., PLCδ-PH for PI(4,5)P2) can visualize the impact of acyl chain remodeling on phosphoinositide distribution and nanodomain formation. Super-resolution microscopy can resolve nanoscale organization.
Biochemical Assays
In vitro enzyme assays using recombinant proteins and synthetic substrates can measure phospholipase and acyltransferase activities. Such assays help determine substrate specificity and kinetic parameters.
How CRISPR Can Be Used to Study GO:0036149 phosphatidylinositol acyl-chain remodeling
Knockout
CRISPR knockout of genes such as MBOAT7 or PLA1 allows researchers to assess their necessity in PI acyl-chain remodeling. For example, MBOAT7 knockout in liver cells leads to altered PI species and activation of oncogenic pathways. Knockout models are invaluable for determining causal roles in disease.
Point Mutation
Introducing specific point mutations via CRISPR (e.g., in DDHD1) can mimic human disease alleles and reveal how single amino acid changes affect enzyme activity and PI composition. This approach is crucial for understanding structure-function relationships.
Knock-in
Knock-in of tagged versions of remodeling enzymes (e.g., GFP-MBOAT7) enables live-cell imaging and proteomic studies. Knock-in of disease-associated mutations in model organisms can recapitulate human phenotypes.
Overexpression
CRISPR activation (CRISPRa) or traditional overexpression can elevate levels of remodeling enzymes to study gain-of-function effects. Overexpression of LPLAT can increase specific PI species and modulate signaling.
How EDITGENE Supports phosphatidylinositol acyl-chain remodeling Research
Researchers studying phosphatidylinositol acyl-chain remodeling-related genes often need to determine whether a candidate gene is causally involved in lipid metabolism, signaling, or disease. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for phosphatidylinositol acyl-chain remodeling research.
Frequently Asked Questions About phosphatidylinositol acyl-chain remodeling
What is phosphatidylinositol acyl-chain remodeling?
It is the biological process (GO:0036149) that exchanges fatty acid chains on phosphatidylinositol through deacylation and re-acylation, generating PI molecules with different acyl chain compositions.
What genes are involved in phosphatidylinositol acyl-chain remodeling?
Key genes include MBOAT7, PLA1 (e.g., DDHD1), LPLAT, and PITP family members, which encode enzymes that remove or add acyl chains to PI.
Why is phosphatidylinositol acyl-chain remodeling important?
It determines the biophysical properties of PI and its phosphorylated derivatives, affecting membrane organization, protein recruitment, and signaling pathways.
How is phosphatidylinositol acyl-chain remodeling studied?
Common methods include mass spectrometry lipidomics, CRISPR knockout/knock-in, fluorescence microscopy, and enzyme activity assays.
What diseases are linked to defects in phosphatidylinositol acyl-chain remodeling?
Dysregulation has been implicated in cancer, neurodegeneration (e.g., hereditary spastic paraplegia), and metabolic disorders such as NAFLD.
What is the role of MBOAT7 in phosphatidylinositol acyl-chain remodeling?
MBOAT7 is a lysophosphatidylinositol acyltransferase that incorporates arachidonic acid into PI, and its loss alters PI composition and promotes liver tumorigenesis.
How does acyl chain saturation affect phosphatidylinositol 4,5-bisphosphate nanodomains?
Acyl chain saturation regulates the order of PI(4,5)P2 nanodomains, influencing their stability and ability to recruit signaling proteins.
Can CRISPR be used to study phosphatidylinositol acyl-chain remodeling?
Yes, CRISPR knockout, knock-in, and point mutation models are powerful tools to dissect the causal roles of remodeling enzymes in cells and organisms.
What is the difference between phosphatidylinositol acyl-chain remodeling and phosphoinositide synthesis?
Remodeling modifies the fatty acid chains of PI without changing the inositol headgroup, while synthesis involves phosphorylation of the inositol ring to produce phosphoinositides.
Where does phosphatidylinositol acyl-chain remodeling occur in the cell?
It primarily occurs in the endoplasmic reticulum, but remodeled PI species are transported to other membranes such as the plasma membrane and Golgi.
Conclusion
Phosphatidylinositol acyl-chain remodeling (GO:0036149) is a fundamental biological process that generates the remarkable diversity of PI molecular species required for membrane organization and signaling. The enzymes involved, including phospholipases and acyltransferases, are conserved across species and are increasingly linked to human diseases such as cancer and neurodegeneration. Continued research using advanced CRISPR models and lipidomics will further illuminate the mechanistic details and therapeutic potential of this pathway.
References
- 1. Patton-Vogt J et al.. 2020. Phospholipid turnover and acyl chain remodeling in the yeast ER.. Biochim Biophys Acta Mol Cell Biol Lipids 1865(1):158462 PMID: 31146038
- 2. Borges-Araújo L et al.. 2021. Acyl-chain saturation regulates the order of phosphatidylinositol 4,5-bisphosphate nanodomains.. Commun Chem 4(1):164 PMID: 36697613
- 3. Renne MF et al.. 2015. Lipid Acyl Chain Remodeling in Yeast.. Lipid Insights 8(Suppl 1):33-40 PMID: 26819558
- 4. Barneda D et al.. 2022. Acyl chain selection couples the consumption and synthesis of phosphoinositides.. EMBO J 41(18):e110038 PMID: 35771169
- 5. Hunt AN et al.. 2004. Acyl chain-based molecular selectivity for HL60 cellular phosphatidylinositol and of phosphatidylcholine by phosphatidylinositol transfer protein alpha.. Biochim Biophys Acta 1686(1-2):50-60 PMID: 15522822
- 6. Barneda D et al.. 2025. Phosphoinositide acyl chain diversity: comparative analysis across species and mouse tissues.. Biochim Biophys Acta Mol Cell Biol Lipids 1870(6):159640 PMID: 40447253
- 7. Schneiter R et al.. 1999. Electrospray ionization tandem mass spectrometry (ESI-MS/MS) analysis of the lipid molecular species composition of yeast subcellular membranes reveals acyl chain-based sorting/remodeling of distinct molecular species en route to the plasma membrane.. J Cell Biol 146(4):741-54 PMID: 10459010
- 8. Imae R et al.. 2010. Intracellular phospholipase A1 and acyltransferase, which are involved in Caenorhabditis elegans stem cell divisions, determine the sn-1 fatty acyl chain of phosphatidylinositol.. Mol Biol Cell 21(18):3114-24 PMID: 20668164
